O. Usmani (London, United Kingdom), N. Roche (Paris, France), F. Trinkmann (Mannheim, Germany), A. Tiotiu (Nancy, France)
Evaluation of inhalation technique in patients using Dry Powder Inhaler (DPI), and the effect of patient education on their techniques- an experience from Nepal
S. Shrestha (Dhulikhel, Nepal), S. Shrestha (Dhulikhel, Nepal), M. Baral (Dhulikhel, Nepal), S. Bhandari (Dhulikhel, Nepal), S. Chand (Dhulikhel, Nepal), P. Dhakal (Dhulikhel, Nepal), R. Tamrakar (Dhulikhel, Nepal), R. Mehta (Dhulikhel, Nepal), N. Vaidhya (Dhulikhel, Nepal), S. Shrestha (Dhulikhel, Nepal), B. Prajapati (Dhulikhel, Nepal), R. Pandey (Dhulikhel, Nepal), A. Shrestha (Dhulikhel, Nepal), H. Shrestha (Dhulikhel, Nepal)
|  |
Standardising inhaler technique videos in a clinician and patient app
A. Saleem (London, United Kingdom), D. Attar-Zadeh (London, United Kingdom), J. Khambh (London, United Kingdom), T. Root (London, United Kingdom), B. Rehman (London, United Kingdom), V. Mak (London, United Kingdom), O. Usmani (London, United Kingdom)
|  |
Asthma control and COPD symptom burden: results from a multi-country observational study (SPRINT) in patients using fixed dose combination (FDC) inhalers
N. Roche (Paris, France), V. Plaza (Barcelona, Spain), V. Backer (Copenhagen, Denmark), J. Van Der Palen (Enschede, Netherlands), I. Cerveri (Pavia, Italy), C. Gonzalez (Valencia, Spain), G. Safioti (Amsterdam, Netherlands), I. Scheepstra (Amsterdam, Netherlands), O. Patino (Amsterdam, Netherlands), D. Singh (Manchester, United Kingdom)
| |
What influences the response to training of inhalation technique in patients with asthma and COPD?
I. Domagala (Warszawa, Poland), M. Dabrowska (Warszawa, Poland), M. Miszczuk (Warszawa, Poland), K. Luczak (Warszawa, Poland), M. Maskey-Warzechowska (Warszawa, Poland), R. Krenke (Warszawa, Poland)
| |
A novel approach of using pharmaceutical pictogram for improving asthma inhaler techniques
B. Almomani (Irbid, Jordan), E. Mokhemer (Irbid, Jordan)
| |
Inhaler preferences and satisfaction of asthma and COPD patients
J. Kocks (Groningen, Netherlands), L. van Dijk (Groningen, Netherlands), J. Luers ('s Hertogenbosch, Netherlands), H. El Messlaki ('s Hertogenbosch, Netherlands), X. Van Jaarsveld (Amersfoort, Netherlands), E. Metting (Groningen, Netherlands)
| |
Differences in inhaler misuse between patients with asthma and COPD.
M. Miszczuk (Warsaw , Poland), M. Dabrowska (Warsaw , Poland), I. Domagala (Warsaw , Poland), K. Luczak (Warsaw , Poland), M. Maskey-Warzechowska (Warsaw , Poland), R. Krenke (Warsaw , Poland)
| |
Switch to Budesonide/Formoterol Easyhaler Inhalation from other inhalers in asthma patients; A real-life study
G. Gálffy (Budapest, Hungary), M. Szilasi (Debrecen, Hungary)
| |
Importance of inhaler device use status in the control of asthma and COPD: a real life study.
A. Bragantini (Genova, Italy), T. Aloè (Genova, Italy), T. Bondavalli (Genova, Italy), D. Bagnasco (Genova, Italy), G. Passalacqua (Genova, Italy)
| |
Pharmacokinetics (PK) and safety of budesonide/glycopyrronium/formoterol fumarate dihydrate (BGF) and glycopyrronium/formoterol fumarate dihydrate (GFF) metered dose inhaler (MDI) in healthy Chinese adults
H. Yu (Shanghai, China), Y. Liu (Shanghai, China), K. Shen (Shanghai, China), P. Assam (Shanghai, China), M. Gillen (Gaithersburg, United States of America), P. Dorinsky (Durham, United States of America)
| |
Efficacy and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler (GFF MDI) delivered using co-suspension delivery technology in Japanese patients with moderate-to-very severe COPD
Y. Gon (Tokyo, Japan), K. Nishi (Ishikawa, Japan), K. Sato (Niigata, Japan), A. Maes (Morristown, United States of America), S. Siddiqui (Gaithersburg, United States of America), N. Hayashi (Osaka, Japan), H. Hirata (Osaka, Japan), C. Reisner (Morristown, United States of America), U. Martin (Gaithersburg, United States of America)
| |
Lung deposition of extrafine inhaled corticosteroid (ICS)-containing fixed combinations drug in COPD patients using Functional Respiratory Imaging (FRI).
O. Usmani (London, United Kingdom), W. Vos (Kontich, Belgium), B. Mignot (Kontich, Belgium), G. Georges (Cary, United States of America), M. Scuri (Parma, Italy), I. Valente (Parma, Italy), R. De Maria (Parma, Italy), N. Scichilone (Palermo, Italy)
| |
Hyaluronic acid improves tolerability to 7% hypertonic saline solution in bronchiectasis patients
L. Maiz (Madrid, Spain), R. Giron (Madrid, Spain), E. Prats (Madrid, Spain), M. Clemente (Oviedo, Spain), E. Polverino (Barcelona, Spain), S. Caño (Barcelona, Spain), R. Cordovilla (Salamanca, Spain), J. Dorca (Barcelona, Spain), C. PeñAlver (Murcia, Spain), F. Baranda (Vizcaya, Spain), M. Martinez-Garcia (Valencia, Spain)
| |
Efficacy of the device in targeting tiotropium to the small airways in COPD
M. Biddiscombe (London, United Kingdom), A. Saleem (London, United Kingdom), S. Meah (London, United Kingdom), V. Mak (London, United Kingdom), O. Usmani (London, United Kingdom), A. Pellowe (Amanda.pellowe@yale.edu / Yale University,New Haven), J. Li (jia.li.jl2875@yale.edu / Shanghai Jiao Tong University,Shanghai), X. Peng (xueyan.peng@yale.edu / Yale University,New Haven), A. Gonzalez (Anjelica.gonzalez@yale.edu / Yale University,New Haven), E. Herzog (erica.herzog@yale.edu / Yale University,New Haven)
| |
Consistency of aerosol characteristics at low flow rates for a novel mesh nebulizer
J. Pritchard (Chichester, United Kingdom), L. Slator (Chichester, United Kingdom), D. Von Hollen (Murrysville, United States of America)
| |
Reusable soft mist inhaler: maintaining aerosol performance
H. Wachtel (Ingelheim am Rhein, Germany), M. Hänsel (Ingelheim am Rhein, Germany), J. Eicher (Ingelheim am Rhein, Germany)
| |
DuoResp Spiromax adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD (SPRINT)
J. van der Palen (Enschede, Netherlands), I. Cerveri (Pavia, Italy), N. Roche (Paris, France), D. Singh (Manchester, United Kingdom), V. Plaza (Barcelona, Spain), C. Gonzalez (Valencnia, Spain), O. Patino (Amsterdam, Netherlands), I. Scheepstra (Amsterdam, Netherlands), G. Safioti (Amsterdam, Netherlands), V. Backer (Copenhagen, Denmark)
| |
Reduced environmental impact of a reusable soft mist inhaler
M. Hänsel (Ingelheim am Rhein, Germany), T. Bambach (Ingelheim am Rhein, Germany), H. Wachtel (Ingelheim am Rhein, Germany)
| |
Comparing Lung Geometrical Areas of interest in Gamma Scintigraphy as Assessment Tool for Inhaled Drug Deposition
A. Ghazwani (Dhahran, Saudi Arabia), M. Biddiscombe (London, United Kingdom), O. Usmani (London, United Kingdom)
| |
Revealing the regional localization and lung retention of inhaled drugs
E. Bäckström (Gothenburg, Sweden), G. Hamm (Cambridge, United Kingdom), M. Brülls (Gothenburg, Sweden), R. Goodwin (Cambridge, United Kingdom), M. Fridén (Gothenburg, Sweden)
| |